On the Oral Microbiome of Oral Potentially Malignant and Malignant Disorders: Dysbiosis, Loss of Diversity, and Pathogens Enrichment.

Humans Mouth Neoplasms / pathology Carcinoma, Squamous Cell / pathology Dysbiosis RNA, Ribosomal, 16S / genetics Leukoplakia, Oral Microbiota
16S rRNA Campylobacter head and neck cancer microbiota oral cancer oral leukoplakia pathogens

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Feb 2023
Historique:
received: 13 01 2023
revised: 03 02 2023
accepted: 06 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

The role of dysbiosis in the development and progression of oral potentially malignant disorders (OPMDs) remains largely unknown. Here, we aim to characterize and compare the oral microbiome of homogeneous leucoplakia (HL), proliferative verrucous leukoplakia (PVL), oral squamous cell carcinoma (OSCC), and OSCC preceded by PVL (PVL-OSCC). Fifty oral biopsies from HL (

Identifiants

DOI: 10.3390/ijms24043466 PMID: 36834903 PMC: PMC9961214
pubmed: 36834903
pii: ijms24043466
doi: 10.3390/ijms24043466
pmc: PMC9961214
pii:
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI19/00790

Références

Cancer Cell Int. 2022 Mar 26;22(1):135
pubmed: 35346218
J Periodontal Res. 2017 Jun;52(3):636-643
pubmed: 28177125
Kansenshogaku Zasshi. 1993 Jul;67(7):622-8
pubmed: 8360517
Science. 2011 May 27;332(6033):1097-100
pubmed: 21551032
Neoplasia. 2022 Sep;31:100813
pubmed: 35834946
Front Cell Infect Microbiol. 2017 Sep 21;7:403
pubmed: 28983467
Clin Infect Dis. 2005 Jul 1;41(1):e1-4
pubmed: 15937752
Nat Rev Microbiol. 2020 Sep;18(9):521-538
pubmed: 32457482
Nucleic Acids Res. 2013 Jan 7;41(1):e1
pubmed: 22933715
Biomed Pharmacother. 2016 Dec;84:552-558
pubmed: 27693964
Front Immunol. 2021 Jun 04;12:684824
pubmed: 34149727
Front Microbiol. 2019 Aug 02;10:1780
pubmed: 31428073
ISME J. 2017 Sep;11(9):2075-2089
pubmed: 28534880
Periodontol 2000. 2014 Feb;64(1):111-26
pubmed: 24320959
J Oral Pathol Med. 2007 Nov;36(10):575-80
pubmed: 17944749
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Oral Oncol. 2004 Sep;40(8):835-40
pubmed: 15288840
J Transl Med. 2005 Jul 07;3:27
pubmed: 15987522
Oral Dis. 2021 Nov;27(8):1862-1880
pubmed: 33128420
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2406-12
pubmed: 19745222
Front Microbiol. 2017 Dec 01;8:2391
pubmed: 29250055
Eur J Med Res. 2021 Jul 31;26(1):82
pubmed: 34332608
Head Neck Pathol. 2018 Dec;12(4):500-510
pubmed: 29427033
Front Microbiol. 2022 Feb 09;13:795777
pubmed: 35222330
J Dent Res. 2018 Jun;97(6):725-732
pubmed: 29630846
J Med Microbiol. 2022 Aug;71(8):
pubmed: 35921227
Nat Rev Dis Primers. 2020 Nov 26;6(1):92
pubmed: 33243986
Front Cell Infect Microbiol. 2022 Mar 31;12:841465
pubmed: 35433507
mSystems. 2020 Jul 7;5(4):
pubmed: 32636333
Oral Dis. 2022 Sep 12;:
pubmed: 36093607
Oral Oncol. 2021 Sep;120:105404
pubmed: 34225130
PLoS One. 2014 Mar 18;9(3):e92297
pubmed: 24642836
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Oral Dis. 2021 Nov;27(8):1881-1895
pubmed: 33606345
Clin Otolaryngol. 2014 Oct;39(5):272-80
pubmed: 25099922
Clin Chim Acta. 2020 Jul;506:191-195
pubmed: 32220421
Gut. 2018 Jun;67(6):1024-1032
pubmed: 28765474
J Oral Microbiol. 2020 Dec 9;13(1):1857998
pubmed: 33391629
Front Microbiol. 2018 May 03;9:862
pubmed: 29774014
Front Cell Infect Microbiol. 2020 Jan 15;9:476
pubmed: 32010645
Oral Dis. 2018 Jul;24(5):749-760
pubmed: 29337414
Arch Microbiol. 2021 Jan;203(1):137-152
pubmed: 32783067
Clin Oral Investig. 2022 Aug;26(8):5181-5188
pubmed: 35474554
PLoS One. 2012;7(5):e38217
pubmed: 22666490
Clin Oral Investig. 2020 Jun;24(6):1963-1969
pubmed: 31440840
ISME J. 2010 Aug;4(8):962-74
pubmed: 20336157
Oral Dis. 2021 Nov;27(8):1896-1907
pubmed: 34009718
Periodontol 2000. 2014 Feb;64(1):139-53
pubmed: 24320961
Carcinogenesis. 2021 Feb 11;42(1):127-135
pubmed: 32621740
BMC Microbiol. 2014 Dec 17;14:316
pubmed: 25515234
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
J Oral Pathol Med. 1995 May;24(5):193-7
pubmed: 7616456
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Aug;102(2):259-64
pubmed: 16876072
Gut. 2019 Feb;68(2):289-300
pubmed: 30377189
BMC Microbiol. 2012 Jul 20;12:144
pubmed: 22817758
Oral Dis. 2015 Sep;21(6):748-54
pubmed: 25809116
Arch Microbiol. 2018 May;200(4):525-540
pubmed: 29572583
Database (Oxford). 2010 Jul 06;2010:baq013
pubmed: 20624719
Theranostics. 2020 Sep 18;10(25):11595-11606
pubmed: 33052235

Auteurs

Alejandro Herreros-Pomares (A)

Department of Biotechnology, Universitat Politècnica de València, 46022 Valencia, Spain.
Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.
ORCID: 0000-0003-3838-097X

David Hervás (D)

Department of Applied Statistics and Operational Research, and Quality, Universitat Politècnica de València, 46022 Valencia, Spain.
ORCID: 0000-0003-0635-4961

Leticia Bagan-Debón (L)

Medicina Oral Unit, Stomatology Department, Valencia University, 46010 Valencia, Spain.

Eloísa Jantus-Lewintre (E)

Department of Biotechnology, Universitat Politècnica de València, 46022 Valencia, Spain.
Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.
ORCID: 0000-0001-7395-4380

Concepción Gimeno-Cardona (C)

Department of Microbiology, Hospital General Universitario de Valencia, 46014 Valencia, Spain.

José Bagan (J)

Centro de Investigación Biomédica en Red Cáncer (CIBERONC), 28029 Madrid, Spain.
Medicina Oral Unit, Stomatology Department, Valencia University, 46010 Valencia, Spain.
Department of Stomatology and Maxillofacial Surgery, Hospital General Universitario de Valencia, 46014 Valencia, Spain.
Precancer and Oral Cancer Research Group, Valencia University, 46010 Valencia, Spain.
ORCID: 0000-0002-0295-2916

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

Recherchemedicale.com › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › On the Oral Microbiome of Oral Potentially...
Recherchemedicale.com › Maladies du système stomatognathique › Maladies de la bouche › Tumeurs de la bouche › On the Oral Microbiome of Oral Potentially...
Recherchemedicale.com › Tumeurs › Tumeurs par type histologique › Tumeurs épithéliales épidermoïdes et glandulaires › Tumeurs épidermoïdes › Carcinome épidermoïde › On the Oral Microbiome of Oral Potentially...
Recherchemedicale.com › États, signes et symptômes pathologiques › Processus pathologiques › Dysbiose › On the Oral Microbiome of Oral Potentially...
Recherchemedicale.com › Acides nucléiques, nucléotides et nucléosides › Acides nucléiques › ARN › ARN ribosomique › ARN ribosomique 16S › On the Oral Microbiome of Oral Potentially...
Recherchemedicale.com › États, signes et symptômes pathologiques › États anatomopathologiques › Leucoplasie › Leucoplasie buccale › On the Oral Microbiome of Oral Potentially...
Recherchemedicale.com › Environnement et santé publique › Environnement › Écosystème › Biodiversité › Biote › Microbiote › On the Oral Microbiome of Oral Potentially...